New
Service for TodaysSeniorsNetwork.com
readers...roll mouse over, click on
highlighted links in stories to review items
from Amazon
Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Surgical site
infections more common than expected
following breast procedures
Infections at the incision
site occurred in more than 5 percent of
patients following breast surgery and cost
them more than $4,000 each in
hospital-related expenses, according to a
report in the January issue of Archives of
Surgery, one of the JAMA/Archives journals.
Reported surgical site
infection rates following mastectomy
(surgical removal of the breast) and other
breast procedures range from 1 percent to 28
percent, according to background information
in the article.
“Given the state of fiscal
constraints within the U.S. health care
system, it is important to calculate the
cost-effectiveness of infection control
interventions to justify their use from an
economic perspective,” the authors write.
“Cost-effectiveness
analyses require accurate estimates for the
attributable costs of hospital-acquired
infections, which are lacking for surgical
site infections.”
Margaret A. Olsen, Ph.D.,
M.P.H., of the Washington University School
of Medicine, St. Louis, and colleagues
studied 949 hospital admissions for
mastectomy or breast reconstruction
procedures at a university-affiliated
hospital between 1999 and 2002.
Surgical site
infections were identified in an electronic
hospital database and verified by review of
medical records.
Costs were taken from the
hospital accounting database and included
those from the original admission to the
hospital for surgery as well as any
readmissions within one year of surgery.
Surgical site infections were
identified in 50 women within one year of
surgery (5.3 percent). Infections were more
common in patients undergoing cancer-related
procedures, and occurred following 12.4
percent of mastectomies with immediate
breast reconstruction using an implant; 6.2
percent of mastectomies with immediate
breast reconstruction using abdominal
tissue; 4.4 percent of mastectomies only and
1.1 percent of breast reduction surgeries.
The average time between
surgery and infection diagnosis was 46.6
days.
“Patients with surgical site
infections had significantly higher hospital
costs associated with surgery and during the
one-year period after surgery compared with
uninfected patients, and they had a
significantly longer total length of
hospital stay,” the authors write.
After adjusting for the
type of surgical procedure performed, breast
cancer stage and other variables that
influence cost, the cost of surgical site
infections was $4,091 per patient.
“Potential interventions to
reduce the incidence of surgical site
infections in this patient population
include strategies to optimize the timing
and dosage of prophylactic antibiotics
administered before the surgical incision,
glucose control in diabetic patients,
promotion of meticulous hand hygiene and
strategies to promote timely removal of
drains, among others,” the authors conclude.
“Interventions to reduce the
incidence of surgical site infections
following breast cancer surgical procedures
are essential to reduce not only morbidity
in these patient populations but also costs
to the individuals and to society.”